Bespoke Extracts Past Earnings Performance
Past criteria checks 0/6
Bespoke Extracts's earnings have been declining at an average annual rate of -14.3%, while the Pharmaceuticals industry saw earnings growing at 1% annually. Revenues have been growing at an average rate of 75.4% per year.
Key information
-14.3%
Earnings growth rate
12.2%
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | 75.4% |
| Return on equity | n/a |
| Net Margin | -188.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Bespoke Extracts makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1 | -1 | 2 | 0 |
| 30 Sep 23 | 1 | -2 | 2 | 0 |
| 30 Jun 23 | 0 | -3 | 3 | 0 |
| 31 Mar 23 | 0 | -4 | 4 | 0 |
| 31 Dec 22 | 0 | -4 | 4 | 0 |
| 30 Sep 22 | 0 | -3 | 3 | 0 |
| 30 Jun 22 | 0 | -2 | 2 | 0 |
| 31 Mar 22 | 0 | -1 | 2 | 0 |
| 31 Dec 21 | 0 | 0 | 1 | 0 |
| 30 Nov 21 | 0 | -1 | 1 | 0 |
| 31 Aug 21 | 0 | -1 | 1 | 0 |
| 31 May 21 | 0 | -1 | 1 | 0 |
| 28 Feb 21 | 0 | -4 | 4 | 0 |
| 31 Dec 20 | 0 | -1 | 1 | 0 |
| 30 Nov 20 | 0 | -4 | 4 | 0 |
| 31 Aug 20 | 0 | -5 | 4 | 0 |
| 31 May 20 | 0 | -5 | 4 | 0 |
| 29 Feb 20 | 0 | -2 | 1 | 0 |
| 30 Nov 19 | 0 | -2 | 1 | 0 |
| 31 Aug 19 | 0 | 3 | -3 | 0 |
| 31 May 19 | 0 | 1 | -1 | 0 |
| 28 Feb 19 | 0 | -1 | 1 | 0 |
| 30 Nov 18 | 0 | -3 | 2 | 0 |
| 31 Aug 18 | 0 | -8 | 7 | 0 |
| 31 May 18 | 0 | -7 | 6 | 0 |
| 28 Feb 18 | 0 | -9 | 9 | 0 |
| 30 Nov 17 | 0 | -8 | 8 | 0 |
| 31 Aug 17 | 0 | -7 | 7 | 0 |
| 31 May 17 | 0 | -5 | 5 | 0 |
| 28 Feb 17 | 0 | 0 | 0 | 0 |
| 30 Nov 16 | 0 | 0 | 0 | 0 |
| 31 Aug 16 | 0 | 0 | 0 | 0 |
| 31 May 16 | 0 | -1 | 0 | 0 |
| 29 Feb 16 | 0 | -1 | 0 | 0 |
| 30 Nov 15 | 0 | -1 | 0 | 0 |
| 31 Aug 15 | 0 | -1 | 0 | 0 |
| 31 May 15 | 0 | 0 | 0 | 0 |
| 28 Feb 15 | 0 | 0 | 0 | 0 |
| 30 Nov 14 | 0 | 0 | 0 | 0 |
| 31 Aug 14 | 0 | 0 | 0 | 0 |
| 31 May 14 | 0 | 0 | 0 | 0 |
| 28 Feb 14 | 0 | 0 | 0 | 0 |
| 30 Nov 13 | 0 | 0 | 0 | 0 |
| 31 Aug 13 | 0 | 0 | 0 | 0 |
Quality Earnings: BSPK is currently unprofitable.
Growing Profit Margin: BSPK is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BSPK is unprofitable, and losses have increased over the past 5 years at a rate of 14.3% per year.
Accelerating Growth: Unable to compare BSPK's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BSPK is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-13.2%).
Return on Equity
High ROE: BSPK's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.